Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 5–Jul 12, 2026)
Here’s what’s on the biotech calendar for July 5–July 12: 2 FDA decision dates, 0 trial catalysts, and 0 earnings reports from tracked companies.
💊 FDA Decisions (PDUFA Dates)
| Date | Ticker | Drug | Indication | Type |
|---|---|---|---|---|
| 2026-07-07 | VERA | — | IgAN in adults | BLA |
| 2026-07-11 | CORT | — | Platinum-Resistant Ovarian Cancer <P STYLE=”margin- | NDA |
📡 Run-up Radar Highlights
Stocks entering the pre-catalyst window with the strongest setups (full radar is a Premium feature):
- VERA — BLA in 2 days, score 69/100
- CELC — NDA in 12 days, score 65/100
- ACIU — Phase 1 — Recruiting in 27 days, score 48/100
📈 Last Week’s Biggest Gainers
- DSC +39.67% (volume 1.5x average)
- ABVX +38.60% (volume 4.8x average)
- SLBT +34.61% (volume 1.6x average)
- RGC +31.86% (volume 16.8x average)
- AMBA +28.04% (volume 5.7x average)
Track your tickers on the BioRadar dashboard →
This digest is for informational purposes only and is not investment advice. Always do your own research.